US$ 22.94
glp-1 competitive landscape Agonists Market Exclusive Research Report 2025 GLP-1 Market Shift: Semaglutide, Tirzepatide
Description
Use Great for any vegan or keto individuals who want to watch their sugar intake
Much anticipated Phase II results in obesity for Amgens GLP-1 agonist/GIP antagonist showed up to 20% weight loss, but without detailed data the drugs competitiveness is hard to ascertain.

GLP-1s slow down gastric emptying, which means food stays in your stomach longerhelping you feel full, but also potentially causing bloating or discomfort

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.
